Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer-Reference-Cited by-同舟云学术

Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer

Published:2016-02-01 Issue:2 Volume:2 Page:242
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Datta Jashodeep¹,Fracol Megan¹,McMillan Matthew T.¹,Berk Erik¹,Xu Shuwen¹,Goodman Noah²,Lewis David A.²,DeMichele Angela³,Czerniecki Brian J.⁴

Affiliation:

1. Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia

2. Division of Medical Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia

3. Division of Medical Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia3Department of Epidemiology and Biostatistics, Hospital of the University of Pennsylvania, Philadelphia

4. Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia4Rena Rowen Breast Center, Hospital of the University of Pennsylvania, Philadelphia

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation;Human Immunology;2024-07

2. Expression analysis of lymphocyte subsets and lymphocyte-to-monocyte ratio: reveling immunosuppression and chronic inflammation in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-01

3. Breast cancer vaccination: Latest advances with an analytical focus on clinical trials;International Immunopharmacology;2023-10

4. Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells;F1000Research;2023-09-08

5. LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer;Cancers;2023-05-16